Kwality Pharma

Kwality_Pharma26 Apr 2024

Pharmaceuticals

₹

+6.80 (+1.36%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Kwality Pharma

Kwality Pharma

Pharmaceuticals

Kwality_Pharma26 Apr 2024

₹

+6.80 (+1.36%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date	Ratio
22-Dec-2016	D	Kwality Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on December 22, 2016, inter-alia has considered and approved interim dividend @ 6% i.e. Re. 0.60 (Sixty Paise only) per equity share of Rs. 10/- each on the equity share capital of the company for the year 2016-17. The Board Meeting commenced at 04:00 P.M and concluded at 05:45 P.M. The dividend is expected to be paid /dispatched as per applicable provisions of the SEBI (LODR) Regulations, 2015 and Companies Act, 2013.	05-Jan-2017
06-Oct-2017	B	1:1 Bonus Issue of Equity Shares Trading Members of the Exchange are hereby informed that, Kwality Pharmaceuticals Ltd. has fixed the record date for the purpose of Bonus Issue. The transactions in the equity shares of the company would be on an ex-bonus basis with effect from the under mentioned date. DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE Kwality Pharmaceuticals Ltd. (539997) RECORD DATE 12/10/2017 PURPOSE Issue of 1 (ONE) Bonus equity share for every 1 (ONE) existing equity share held. Ex-Bonus basis from Date & Sett. No. 11/10/2017 DR-133/2017-2018 Trading Members of the Exchange are requested to take note of it. (As Per BSE Notice Dated on 09.10.2017)	12-Oct-2017	1:1
26-Feb-2024	BC	Aditya Arora	16-Feb-2024
16-Feb-2024	BC	Aditya Arora & PACs	15-Feb-2024
25-Jan-2024	BC	Kwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2024 inter alia to consider and approve the Standalone and Consolidated Una	06-Feb-2024
17-Oct-2023	BC	Kwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2023 inter alia to consider and approve the Unaudited Standalone and Consol	04-Nov-2023
08-Sep-2023	BC	AGM 30/09/2023 Outcome of Board meeting held on September 06, 2023 (As Per BSE Announcement Dated on 06.09.2023) Disclosure of E Voting Results and Scrutinizer''s Report of 40th AGM (As p	30-Sep-2023

No Rights has been declared by Kwality_Pharma

Book Closure

Record Date	Split Date	Purpose
16-Feb-2024	-	Aditya Arora
15-Feb-2024	-	Aditya Arora & PACs
06-Feb-2024	-	Kwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2024 inter alia to consider and approve the Standalone and Consolidated Una
04-Nov-2023	-	Kwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2023 inter alia to consider and approve the Unaudited Standalone and Consol
30-Sep-2023	-	AGM 30/09/2023 Outcome of Board meeting held on September 06, 2023 (As Per BSE Announcement Dated on 06.09.2023) Disclosure of E Voting Results and Scrutinizer''s Report of 40th AGM (As p

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Kwality Pharmaceuticals Ltd ₹507.00(+6.80/1.36%)	507.00	+6.80	526.07	36.92	18.52	2.47
Astrazeneca Pharma India Ltd ₹5,415.40(+81.55/1.53%)	5,415.40	+81.55	13,538.50	71.09	84.88	20.67
Bliss GVS Pharma Ltd ₹122.60(+5.85/5.01%)	122.60	+5.85	1,283.51	60.79	18.80	1.31
Cipla Ltd ₹1,409.40(+4.00/0.28%)	1,409.40	+4.00	113,794.25	54.54	34.60	4.40
Abbott India Ltd ₹25,864.85(+201.35/0.78%)	25,864.85	+201.35	54,962.81	15.87	47.98	17.68
Amrutanjan Health Care Ltd ₹680.85(-8.80/-1.28%)	680.85	-8.80	1,968.38	13.21	44.73	7.51

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	78.10	69.65	67.45	68.80	56.01	55.96
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	78.10	69.65	67.45	68.80	56.01	55.96
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.62	0.23	0.40	1.46	0.35	0.75
Total Income	78.71	69.88	67.85	70.26	56.36	56.72
Total Expenditure	61.39	54.38	53.64	73.81	40.84	40.39
PBIDT	17.32	15.50	14.20	-3.55	15.52	16.33
Interest	2.73	2.41	2.19	1.67	1.95	1.18
PBDT	14.59	13.09	12.02	-5.22	13.57	15.14
Depreciation	4.81	4.88	4.78	4.42	3.54	3.83
Tax	2.46	2.15	1.82	-2.45	2.52	2.58
Deferred Tax	-0.39	-0.20	-0.03	0.17	0.28	-0.31
Reported Profit After Tax	7.70	6.26	5.45	-7.36	7.23	9.05
Extra-ordinary Items	0.00	0.00	0.00	-16.36	0.00	0.00
Adjusted Profit After Extra-ordinary item	7.70	6.26	5.45	9.00	7.23	9.05

EPS (Unit Curr.)	7.42	6.03	5.17	-7.15	6.92	8.52
EPS (Adj) (Unit Curr.)	7.42	6.03	5.17	-7.15	6.92	8.52
Calculated EPS (Unit Curr.)	7.42	6.03	5.25	-7.09	6.97	8.72
Calculated EPS (Adj) (Unit Curr.)	7.42	6.03	5.25	-7.09	6.97	8.72
Calculated EPS (Ann.) (Unit Curr.)	29.69	24.12	20.99	-28.36	27.86	34.88
Calculated EPS (Adj) (Ann.) (Unit Curr.)	29.69	24.12	20.99	-28.36	27.86	34.88
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	10.38	10.38	10.38	10.38	10.38	10.38
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	22.18	22.25	21.05	-5.16	27.71	29.18
PBDTM(%)	18.68	18.79	17.82	-7.59	24.23	27.06
PATM(%)	9.86	8.99	8.08	-10.70	12.91	16.17

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	78.10	69.65	67.45	68.80	56.20	55.81
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	78.10	69.65	67.45	68.80	56.20	55.81
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.62	0.23	0.40	1.46	0.35	1.13
Total Income	78.71	69.88	67.85	70.26	56.55	56.93
Total Expenditure	61.41	54.42	53.68	73.85	41.10	40.25
PBIDT	17.30	15.46	14.17	-3.59	15.45	16.68
Interest	2.73	2.41	2.19	1.67	1.95	1.18
PBDT	14.57	13.05	11.98	-5.25	13.50	15.50
Depreciation	4.82	4.88	4.79	4.43	3.55	3.84
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	2.46	2.15	1.82	-2.45	2.52	2.58
Deferred Tax	-0.39	-0.20	-0.03	0.17	0.28	-0.31
Reported Profit After Tax	7.68	6.22	5.40	-7.40	7.14	9.39
Minority Interest After NP	-0.01	-0.02	-0.02	-0.02	0.04	-0.03
Net Profit after Minority Interest	7.69	6.24	5.42	-7.38	7.10	9.42

Extra-ordinary Items	0.00	0.00	0.00	-16.36	0.00	0.00
Adjusted Profit After Extra-ordinary item	7.69	6.24	5.42	8.98	7.10	9.42

EPS (Unit Curr.)	7.39	5.99	5.10	-7.23	6.82	8.82
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	10.38	10.38	10.38	10.38	10.38	10.38

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	22.15	22.20	21.01	-5.22	27.49	29.89
PBDTM(%)	18.66	18.74	17.76	-7.63	24.02	27.77
PATM(%)	9.83	8.93	8.01	-10.76	12.70	16.82

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	10.38	10.38	10.38	10.38	10.38	10.38
Reserves Total	191.65	172.18	52.13	36.72	28.29	20.74
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	202.03	182.56	62.51	47.10	38.67	31.12
Secured Loans	90.15	53.31	32.72	29.42	25.74	24.44
Unsecured Loans	0.12	0.70	8.51	5.55	2.42	1.41
Total Debt	90.27	54.01	41.23	34.97	28.16	25.85
Total Liabilities	292.30	236.57	103.74	82.07	66.83	56.97
APPLICATION OF FUNDS :
Gross Block	168.72	126.70	80.79	61.18	46.26	34.46
Less : Accumulated Depreciation	49.15	35.93	25.27	19.55	18.24	15.19
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	119.57	90.77	55.52	41.63	28.02	19.27
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	14.29	12.15	2.89	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	3.55	3.55	8.72	7.54	8.46	8.54
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	93.37	53.36	17.36	22.42	11.24	14.93
Sundry Debtors	73.29	70.71	37.78	30.35	38.75	37.16
Cash and Bank	6.09	10.87	5.13	1.15	0.28	1.03
Loans and Advances	41.83	92.37	41.17	31.28	20.08	16.57
Total Current Assets	214.57	227.32	101.44	85.19	70.35	69.69
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	56.50	64.08	49.39	39.82	36.22	37.36
Provisions	13.53	41.00	5.80	3.00	3.30	2.60
Total Current Liabilities	70.03	105.08	55.19	42.82	39.52	39.96
Net Current Assets	144.54	122.23	46.25	42.37	30.82	29.72
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.04	0.20	0.32	0.09	0.19
Deferred Tax Liability	0.41	0.31	0.16	0.12	0.21	0.40
Net Deferred Tax	-0.41	-0.27	0.04	0.20	-0.12	-0.21
Total Assets	281.55	228.43	113.42	91.74	67.18	57.32
Contingent Liabilities	0.51	0.05	0.59	1.27	5.29	2.83

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	10.38	10.38	10.38	10.38	10.38	10.38
Reserves Total	190.14	170.77	50.78	35.63	26.92	19.37
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	200.52	181.15	61.16	46.01	37.30	29.75
Minority Interest	-1.45	-1.35	-1.30	-1.04	-0.98	-0.99
Secured Loans	90.15	53.31	32.72	29.42	26.32	25.04
Unsecured Loans	0.12	0.70	8.51	5.55	2.42	1.41
Total Debt	90.27	54.01	41.23	34.97	28.74	26.45
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	0.90	0.75	9.86	9.80	0.52	0.55
Total Liabilities	290.24	234.56	110.95	89.74	65.58	55.76
APPLICATION OF FUNDS :
Gross Block	170.15	128.13	82.22	62.60	47.64	35.82
Less: Accumulated Depreciation	49.66	36.39	25.69	19.91	18.56	15.44
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	120.49	91.74	56.53	42.69	29.08	20.38
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	14.29	12.15	2.89	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	5.17	3.99	4.82	5.34
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	93.37	53.36	17.36	22.42	11.25	15.03
Sundry Debtors	71.69	69.13	35.71	30.33	38.43	37.03
Cash and Bank	7.36	12.95	5.81	1.54	1.40	1.61
Loans and Advances	41.83	92.37	42.58	31.41	20.24	16.61
Total Current Assets	214.25	227.82	101.46	85.69	71.32	70.28
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	56.50	64.77	49.53	39.96	36.38	37.64
Provisions	13.53	41.00	5.80	3.00	3.30	2.60
Total Current Liabilities	70.04	105.77	55.33	42.96	39.68	40.24
Net Current Assets	144.21	122.05	46.13	42.73	31.63	30.05
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.04	0.20	0.32	0.09	0.19
Deferred Tax Liability	0.41	0.31	0.16	0.12	0.21	0.40
Net Deferred Tax	-0.41	-0.27	0.04	0.20	-0.12	-0.21
Other Assets	11.64	8.89	0.17	0.12	0.16	0.19
Total Assets
Contingent Liabilities	0.51	0.05	0.59	1.27	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	7.06	5.13	1.15	0.28	1.03
Net Cash from Operating Activities	42.19	59.24	26.36	5.63	12.96
Net Cash Used In Investing Activities	-48.44	-62.98	-23.20	-17.13	-11.80
Net Cash Used In Financing Activities	0.99	5.66	0.83	12.36	-1.91
Net Inc./Dec In Cash And Cash Equivalents	-5.26	1.93	3.99	0.87	-0.75
Cash And Cash Equivalents At End Of The Year	1.80	7.06	5.13	1.15	0.28

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

54.83%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

45.17%

**Promoter pledged shareholding 54.83%

About Kwality Pharmaceuticals Ltd

Kwality Pharmaceuticals Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 526.07 crores. It has reported a sales of Rs. 78.1 crores and a net profit of Rs. 7.7 crores for the quarter ended December 2018. The company management includes , Ramesh Arora,Ajay Arora,Ravi Shanker Singh,Geeta Arora,Anju Arora,Aditya Arora,Pankaj Takkar,Kiran Kumar Verma,Gurpreet Kaur,Kartik Kapur,Sachin Seth (Kwality Pharmaceuticals Ltd) among others.

Chairman

Registered office

Village Nagkalan,Majitha Road,Amritsar,Punjab,143601

FAX :91-183-2774477

Background

Incorporation Year1983

Face Value₹10

Market Lot1

How to buy Kwality Pharma shares on nse?

To buy Kwality Pharma shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Kwality Pharma share price today?

The Kwality Pharma shares price on nse is Rs.507 today.

What is the market cap of Kwality Pharma shares on BSE ?

The company has a market capitalization of Rs.526.07Cr

What is the PE & PB ratio of Kwality Pharma shares ?

PE is 18.52 and PB is 2.47

What is the 52 Week High and Low of Kwality Pharma shares?

Kwality Pharma stock price high: Rs.545 Kwality Pharma stock price low: Rs.248